Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank64
5Y CAGR-36.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-36.6%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 12.65% |
| Q2 2025 | 28.87% |
| Q1 2025 | 5.85% |
| Q4 2024 | -2.91% |
| Q3 2024 | 6.86% |
| Q2 2024 | 3.97% |
| Q1 2024 | 24.65% |
| Q4 2023 | 12.76% |
| Q3 2023 | -16.28% |
| Q2 2023 | -1.21% |
| Q1 2023 | 16.92% |
| Q4 2022 | -19.93% |
| Q3 2022 | -18.11% |
| Q2 2022 | -10.34% |
| Q1 2022 | 18.25% |
| Q4 2021 | -2.96% |
| Q3 2021 | -97.58% |
| Q2 2021 | -39.03% |
| Q1 2021 | 39.58% |
| Q4 2020 | -1100.00% |
| Q3 2020 | 123.86% |
| Q2 2020 | 54.13% |
| Q1 2020 | 0.00% |